| scholarly article | Q13442814 |
| P2093 | author name string | Michel Khrestchatisky | |
| Yves Molino | |||
| Emmanuelle Lacassagne | |||
| Nicolas Gaudin | |||
| Françoise Jabès | |||
| P2860 | cites work | Paracellular tightness and claudin-5 expression is increased in the BCEC/astrocyte blood-brain barrier model by increasing media buffer capacity during growth | Q24609936 |
| Brain endothelial cell-cell junctions: how to "open" the blood brain barrier | Q24654117 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier | Q28257034 | ||
| Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells | Q33204218 | ||
| Chemokines and chemokine receptors in CNS pathology. | Q33586740 | ||
| The cell biology of the blood-brain barrier. | Q33593387 | ||
| The role of shear stress in Blood-Brain Barrier endothelial physiology | Q33898503 | ||
| In vitro model for evaluating drug transport across the blood-brain barrier | Q33904239 | ||
| Astrocyte-endothelial interactions and blood-brain barrier permeability | Q33960608 | ||
| Dynamics of CNS barriers: evolution, differentiation, and modulation | Q33987878 | ||
| Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. | Q33990556 | ||
| Modelling of the blood-brain barrier in drug discovery and development. | Q34005458 | ||
| Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes | Q34060092 | ||
| Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks | Q34170906 | ||
| A new dynamic in vitro modular capillaries-venules modular system: cerebrovascular physiology in a box. | Q34578713 | ||
| The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). | Q35031901 | ||
| Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation | Q35046911 | ||
| Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons | Q35341255 | ||
| Targeted delivery of proteins across the blood-brain barrier | Q35762072 | ||
| In vitro blood-brain barrier models: current and perspective technologies | Q35782792 | ||
| Drug delivery and in vitro models of the blood-brain barrier | Q36023347 | ||
| In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro | Q36166098 | ||
| Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions | Q36166105 | ||
| Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. | Q36166111 | ||
| A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier | Q36267668 | ||
| Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease | Q36343094 | ||
| TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier | Q36604118 | ||
| A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. | Q36609859 | ||
| Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier | Q36637219 | ||
| Genetic mouse models to study blood-brain barrier development and function | Q36909576 | ||
| Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance | Q36959343 | ||
| A genomic comparison of in vivo and in vitro brain microvascular endothelial cells | Q37086983 | ||
| Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor | Q37573901 | ||
| In vitro models of the blood-brain barrier | Q37866093 | ||
| Patented in vitro blood-brain barrier models in CNS drug discovery. | Q37876433 | ||
| In vitro modeling of the blood-brain barrier: simplicity versus complexity | Q37914237 | ||
| Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes | Q38065213 | ||
| The hCMEC/D3 cell line as a model of the human blood brain barrier | Q38093329 | ||
| In vitro models to study the blood brain barrier. | Q39495418 | ||
| Murine in vitro model of the blood-brain barrier for evaluating drug transport | Q39817035 | ||
| The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells | Q39926929 | ||
| Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies | Q40111896 | ||
| A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2. | Q40274870 | ||
| Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. | Q40303548 | ||
| Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
| Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. | Q40442621 | ||
| Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies | Q40624723 | ||
| Induction of astrocyte differentiation by endothelial cells. | Q40722597 | ||
| GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter | Q40945043 | ||
| Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. | Q41704307 | ||
| A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system | Q42653048 | ||
| Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells | Q43788142 | ||
| Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study. | Q43919045 | ||
| Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability | Q45250155 | ||
| A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes | Q45351723 | ||
| Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. | Q46209146 | ||
| Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. | Q46256906 | ||
| Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. | Q46503083 | ||
| The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model | Q46662946 | ||
| Identification and design of peptides as a new drug delivery system for the brain | Q46835122 | ||
| The value of in vitro models of the blood-brain barrier and their uses. | Q48168496 | ||
| A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters | Q48202764 | ||
| Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier | Q48436806 | ||
| Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier | Q48440083 | ||
| Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability | Q48452108 | ||
| Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study | Q48466858 | ||
| Isolation and culture of microvascular endothelial cells from murine spinal cord | Q48484844 | ||
| Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice | Q48501177 | ||
| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier | Q48520343 | ||
| Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction | Q48599756 | ||
| Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo | Q48643049 | ||
| Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting. | Q48704897 | ||
| Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers | Q48743413 | ||
| An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes | Q48797692 | ||
| Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. | Q48823131 | ||
| Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties | Q48939114 | ||
| Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier. | Q53890861 | ||
| An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. | Q54325285 | ||
| [New protein vectors for physiological transfer of therapeutic agents to the central nervous system]. | Q54470322 | ||
| An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. | Q54546252 | ||
| The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. | Q55475657 | ||
| Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells | Q57283471 | ||
| Vector-mediated drug delivery to the brain | Q57677405 | ||
| Low-density lipoprotein receptor on endothelium of brain capillaries | Q69653609 | ||
| Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal | Q73133716 | ||
| Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier | Q73229643 | ||
| A new model of the blood--brain barrier: co-culture of neuronal, endothelial and glial cells under dynamic conditions | Q73546390 | ||
| In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery | Q83716304 | ||
| Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and | Q84730477 | ||
| Neuronal and glial cell biology | Q93889396 | ||
| Glucose transport to the brain: a systems model | Q94463091 | ||
| P433 | issue | 88 | |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | e51278 | |
| P577 | publication date | 2014-06-28 | |
| P1433 | published in | Journal of Visualized Experiments | Q954500 |
| P1476 | title | Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport |
| Q92257741 | ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas |
| Q48369334 | An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction |
| Q28606583 | Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity |
| Q28067855 | Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking |
| Q60920173 | Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs |
| Q52689356 | Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. |
| Q89483393 | Ethanol's Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells |
| Q33862467 | From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells. |
| Q37630442 | Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. |
| Q37408854 | Gene expression comparison reveals distinct basal expression of HOX members and differential TNF-induced response between brain- and spinal cord-derived microvascular endothelial cells |
| Q59333076 | Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice |
| Q47672573 | Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells. |
| Q48537583 | In Vitro Permeation of FITC-loaded Ferritins Across a Rat Blood-brain Barrier: a Model to Study the Delivery of Nanoformulated Molecules |
| Q36514053 | In vitro model of the blood-brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells |
| Q38730069 | In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. |
| Q37497781 | Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit |
| Q99559824 | Proteoglycan 4 reduces neuroinflammation and protects the blood-brain barrier after traumatic brain injury |
| Q41960885 | Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor |
| Q27009187 | Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury |
| Q92999740 | gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery |
Search more.